EORTC hosting session at ICTR-PHE 2016 in Geneva
9 Dec 2015
The EORTC will host a session at ICTR-PHE 2016, the International Conference on Translational Research in Radio-Oncology – Physics for Health in Europe, from 11:00 – 12:30 on Thursday, 18 February 2016 in Session Room 2 at the Centre International de Conférences Genève in Geneva, Switzerland.
This session will be chaired by Prof Wilfried Budach of Universitaetsklinik in Dusseldorf, Germany. The session will highlight several areas of current EORTC research where the EORTC is making significant contributions towards advancing therapies for patients with cancer.
Speakers include Dr. Damien Weber of the Paul Scherrer Institute Center for Proton Therapy in Villigen, Switzerland, who will present the EORTC radiotherapy quality assurance platform.
Following him, Dr. Sofia Rivera of the Institut Gustave Roussy in Villejuif, France, will discuss Synergy of targeted agents and radiotherapy.
Dr. Rivera will be followed by Dr. Monika Hegi of the Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, who will talk about Lessons from translational research in EORTC Glioma trials.
Dr. Conny Vrieling of the Clinique des Grangettes in Chêne-Bougeries, Switzerland, will close the EORTC session with a talk concerning Data from the EORTC Cancer Survivorship Task Force.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024